Page last updated: 2024-10-21

mercaptoethanol and Carcinoma, Bronchogenic

mercaptoethanol has been researched along with Carcinoma, Bronchogenic in 4 studies

Mercaptoethanol: A water-soluble thiol derived from hydrogen sulfide and ethanol. It is used as a reducing agent for disulfide bonds and to protect sulfhydryl groups from oxidation.

Carcinoma, Bronchogenic: Malignant neoplasm arising from the epithelium of the BRONCHI. It represents a large group of epithelial lung malignancies which can be divided into two clinical groups: SMALL CELL LUNG CANCER and NON-SMALL-CELL LUNG CARCINOMA.

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19903 (75.00)18.7374
1990's1 (25.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bryant, BM1
Jarman, M1
Ford, HT1
Smith, IE1
Matthiessen, W1
Stempinski, E1
Göbel, D1
Thalmann, U1
Holoye, PY1
Glisson, BS1
Lee, JS1
Dhingra, HM1
Murphy, WK1
Umsawasdi, T1
Levy, JK1
Jeffries, D1
Raber, MN1
Hong, WK1
Li, GC1
Brock, N1
Li, JQ1
Guan, ZZ1
He, YJ1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
A Phase Ⅱ Randomized Clinical Trial Comparing Vinorelbine-ifosfamide With Gefitinib as Third-line Treatment in Advanced EGFR Gene Mutation Negative Non-small Cell Lung Cancer Patients[NCT01749072]Phase 2120 participants (Anticipated)Interventional2012-12-31Recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trials

1 trial available for mercaptoethanol and Carcinoma, Bronchogenic

ArticleYear
Prevention of isophosphamide-induced urothelial toxicity with 2-mercaptoethane sulphonate sodium (mesnum) in patients with advanced carcinoma.
    Lancet (London, England), 1980, Sep-27, Volume: 2, Issue:8196

    Topics: Acrolein; Carcinoma, Bronchogenic; Clinical Trials as Topic; Cyclophosphamide; Female; Hematuria; Hu

1980

Other Studies

3 other studies available for mercaptoethanol and Carcinoma, Bronchogenic

ArticleYear
Combination chemotherapy with adriamycin, ifosfamide and mesna in extensive-stage non-small cell bronchogenic carcinoma.
    Cancer treatment reviews, 1983, Volume: 10 Suppl A

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Bronchogenic; Cyclophosphamide; Doxorubic

1983
Ifosfamide with mesna uroprotection in the management of lung cancer.
    American journal of clinical oncology, 1990, Volume: 13, Issue:2

    Topics: Aged; Carcinoma, Bronchogenic; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Female; Humans

1990
Ifosfamide and Mesna in advanced malignancies.
    Chinese medical journal, 1988, Volume: 101, Issue:3

    Topics: Adult; Aged; Carcinoma, Bronchogenic; Female; Hematuria; Humans; Ifosfamide; Lung Neoplasms; Lymphom

1988